Position in EXEL
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,441
New position
Shares Held
100
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#683
of 751 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Markowski Investments holds $81,166 across 9 Biotechnology names. EXEL ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
3,307 | $28,952 | |
| 2 | CRVS |
Corvus Pharmaceuticals, Inc.
|
1,500 | $22,410 | |
| 3 | BMEA |
Biomea Fusion, Inc.
|
5,500 | $8,085 | |
| 4 | JANX |
Janux Therapeutics, Inc.
|
500 | $7,680 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
100 | $5,441 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
20 | $4,819 | |
| 7 | RXRX |
Recursion Pharmaceuticals, Inc.
|
780 | $2,862 | |
| 8 | MREO |
Mereo BioPharma Group plc
|
1,500 | $477 |
All Filings in EXEL
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,441 | 100 | Shares | Sole | 2026-08-13 | |
| No filing history on record for this holder in this stock. | ||||||